WUXI APPTEC
WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. As an innovation-driven and customer-focused company, WuXi AppTec helps our partners improve the productivity of advancing healthcare products through cost-effective and efficient solutions,With industry-leading capabilities such as R&D and manufacturing for s... mall molecule drugs, cell and gene therapies, and testing for medical devices, WuXi AppTec's open-access platform is enabling more than 3,900 collaborators from over 30 countries to improve the health of those in need โ and to realize our vision that "every drug can be made and every disease can be treated".
WUXI APPTEC
Industry:
Biotechnology Health Care Medical Device Outsourcing Pharmaceutical
Founded:
2000-12-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.wuxiapptec.com
Total Employee:
10001+
Status:
Active
Contact:
651-675-2000
Email Addresses:
[email protected]
Total Funding:
1.59 B USD
Technology used in webpage:
SPF SSL By Default Google Analytics LetsEncrypt Google Universal Analytics Domain Not Resolving Global Site Tag Nginx Sitelinks Search Box Amazon
Similar Organizations
Frontier Biotechnologies
Frontier Biotechnologies is a commercial-stage bio-pharmaceutical company.
PCI Pharma Services
PCI Pharma Services is a provider of outsourced services to the global pharmaceutical market.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-03-01 | Oxford Genetics | Oxford Genetics acquired by WuXi AppTec | N/A |
| 2019-05-05 | Pharmapace | Pharmapace acquired by WuXi AppTec | N/A |
| 2017-10-17 | ResearchPoint Global | ResearchPoint Global acquired by WuXi AppTec | N/A |
| 2017-01-19 | HD Biosciences | HD Biosciences acquired by WuXi AppTec | N/A |
| 2016-04-15 | Crelux | Crelux acquired by WuXi AppTec | N/A |
| 2015-01-09 | NextCODE Health | NextCODE Health acquired by WuXi AppTec | 65 M USD |
Investors List
Ping An Bank
Ping An Bank investment in Debt Financing - WuXi AppTec
Warburg Pincus
Warburg Pincus investment in Post-IPO Equity - WuXi AppTec
Eight Roads Ventures
Eight Roads Ventures investment in Series C - WuXi AppTec
Eight Roads Ventures
Eight Roads Ventures investment in Series B - WuXi AppTec
Eight Roads Ventures
Eight Roads Ventures investment in Series A - WuXi AppTec
NewSpring
NewSpring investment in Venture Round - WuXi AppTec
Commerce Health Capital
Commerce Health Capital investment in Venture Round - WuXi AppTec
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-10-20 | ShouTi | WuXi AppTec investment in Series B - ShouTi | 100 M USD |
| 2021-06-03 | Stemirna | WuXi AppTec investment in Venture Round - Stemirna | 1.2 B CNY |
| 2021-05-28 | MegaRobo | WuXi AppTec investment in Corporate Round - MegaRobo | 65 M USD |
| 2021-05-26 | Engine Biosciences | WuXi AppTec investment in Series A - Engine Biosciences | 43 M USD |
| 2021-05-10 | OakMega | WuXi AppTec investment in Series A - OakMega | N/A |
| 2021-02-22 | AnchorDx | WuXi AppTec investment in Series C - AnchorDx | 40 M USD |
| 2021-02-09 | Drug Farm | WuXi AppTec investment in Series A - Drug Farm | 56 M USD |
| 2020-11-17 | D3 Bio | WuXi AppTec investment in Series A - D3 Bio | 200 M USD |
| 2020-06-11 | JW Therapeutics | WuXi AppTec investment in Series B - JW Therapeutics | 100 M USD |
| 2020-05-26 | Insitro | WuXi AppTec investment in Series B - Insitro | 143 M USD |
Newest Events participated
Participated in BioProcess International West 2017
on 2017-02-27 as sponsor
Official Site Inspections
http://www.wuxiapptec.com Semrush global rank: 819.81 K Semrush visits lastest month: 47.12 K
- Host name: 47.111.33.220
- IP address: 47.111.33.220
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "WuXi AppTec" on Search Engine
US Senate bill targeting China's BGI, WuXi AppTec moves forward
Mar 6, 2024 WuXi AppTec, which provides R&D and manufacturing services to the pharmaceutical and healthcare industry, allegedly has ties to the Chinese military, โฆSee details»
Biotech trade association to split with China's WuXi AppTec
Mar 14, 2024 March 13 (Reuters) - A Washington-based global trade association representing biotechnology companies is taking steps to "separate" from Chinese โฆSee details»
Home | WuXi AppTec
As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the โฆSee details»
WuXi AppTec - Wikipedia
WuXi PharmaTech was founded in December 2000 in Shanghai by organic chemist Ge Li. The company opened chemistry facilities in Tianjin in 2007. In 2008, WuXi PharmaTech acquired AppTec Laboratory Services Inc., a US-based company founded in 2001 with expertise in medical-device and biologics testing and with facilities in St. Paul, MN; Philadelphia, PA; and Atlanta, GA. In the same year the company was renamed WuXi AppTec. WuXi AppTec opened โฆSee details»
Exclusive: China's WuXi AppTec shared US client's data with โฆ
March 28 (Reuters) - U.S. intelligence officials in late February told senators working on a biotech security bill that Chinese pharmaceutical firm WuXi AppTec (603259.SS) had โฆSee details»
WuXi AppTec - Crunchbase Company Profile & Funding
Company Type For Profit. Number of Exits. 9. Contact Email [email protected]. Phone Number 651-675-2000. WuXi AppTec provides a broad portfolio of R&D and โฆSee details»
Biotech trade association to split with China's WuXi AppTec
Mar 14, 2024 (Reuters) -A Washington-based global trade association representing biotechnology companies is taking steps to "separate" from Chinese member Wuxi โฆSee details»
WuXi AppTec Receives 2022 Global Contract Research, โฆ
Nov 30, 2022 As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services โฆSee details»
Org Chart WuXi AppTec - The Official Board
WuXi AppTec. has 72 executives and 5 subsidiaries - and belongs to Genuity Science. +86 215 046 1111. Add an executive. WuXi AppTec (603259) News. Anything missing? We โฆSee details»
Biotech Trade Association to Split With China's WuXi AppTec
Mar 13, 2024 (Reuters) -A Washington-based global trade association representing biotechnology companies is taking steps to "separate" from Chinese member Wuxi โฆSee details»
WuXi AppTec Named 2023 Global Contract Research, โฆ
Nov 9, 2023 As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services โฆSee details»
BIO Separates from Chinaโs WuXi AppTec Amid National
Mar 14, 2024 Though headquartered in China, WuXi AppTec is a โglobal companyโ with presence in Europe and North America, according to its website. It provides R&D and โฆSee details»
WuXi AppTec - BIO International Convention | BIO
As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the โฆSee details»
Clinical Research Services | WuXi AppTec
WuXi Clinical, a wholly owned subsidiary of WuXi AppTec, is a global Contract Research Organization (CRO) providing a comprehensive range of services in clinical โฆSee details»
WuXi and BIOโs grip-and-grin - STAT
Apr 18, 2024 The WuXi facility is a big deal in Delaware. The state gave WuXi STA, a U.S. subsidiary of WuXi AppTec, about $19 million in grants for the project, which is โฆSee details»
Homepage | ๅบทๅพทๅผ็ฟผ WuXi Clinical
WuXi Clinical, a wholly owned subsidiary of WuXi AppTec, is a global Contract Research Organization (CRO) providing a comprehensive range of services in clinical โฆSee details»
BOLD - Innovation That Matters - WuXi AppTec
As part of WuXi AppTecโs ongoing efforts to collaboratively foster new thinking and actionable approaches in advancing breakthroughs for patients, we are pleased to share โฆSee details»
Takeda ditches industry trade group BIO following exits by WuXi โฆ
2 days ago Joining a list that recently includes Pfizer, UCB and WuXi AppTec, Takeda Pharmaceuticals is the latest drugmaker to pull out of prominent industry lobbying group โฆSee details»
Home | WuXi AppTec
As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the โฆSee details»
WuXi AppTec - Funding, Financials, Valuation & Investors
$143M. WuXi AppTec has had. 9. exits. WuXi AppTec's most notable exits include Schrödinger , Immunocore , and UNITY Biotechnology. WuXi AppTec has acquired 6 โฆSee details»